Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey

Table 3 Predictors of fatigue among NARCOMS respondents

	Odds Ratio	95% CI
Use of symptomatic drugs	3.85	3.26, 4.55
PDDS	1.38	1.32, 1.43
Age	1.02	1.01,1.03
IMA duration	0.996	0.99, 0.99
Disease duration	0.978	0.97, 0.99
Relapsing-stable vs. Relapsing- worsening MS type	0.434	0.37, 0.51
Primary-progressive vs. Relapsing-worsening MS type	0.233	0.18, 0.31

ISSN: 1477-7525